Novum’s business philosophy has been simple. We provide a high quality, timely and extremely cost effective service to our clients. Our objective is to assist you to get your products approved and to the market as efficiently as possible. Last year the FDA approved over 40 products for marketing where Novum had designed, conducted and reported at least one of the studies in the marketing application.
Novum’s Phase I clinics have built a strong reputation for being at the forefront of scientific design for bioequivalence and bioavailability studies. We can provide you with innovative solutions to performing even the most complicated studies. Our expertise also spreads way beyond oral dosage forms including: injectable, nasal, rectal, vaginal and transdermal products regularly tested.
Our Clinical Trials Division specializes in studies that require large numbers of patients to be recruited quickly in therapeutic areas usually treated in an outpatient setting. Supported by a Data Management Group that specializes in high volume data entry we can significantly reduce your clinical trial timelines.
This website will give you a brief insight into our capabilities. Companies looking for a more information about our capabilities may register to receive a CD which contains a detailed view of the inside of Novum.
If you are an individual looking to participate in a study you can register at www.gonovum.com.
EXPERIENCED: Founded in 1972
FLEXIBLE: Phase I clinics in Houston, Las Vegas and Pittsburgh; 550 beds; Common SOP's amongst the clinics
INNOVATIVE: Specialists in non-traditional drug delivery systems; Topical dosage forms; World leader in Vasoconstrictor studies; CRA Academy
FULL SERVICE: Phase I clinics; Phase II through IV clinical endpoint studies; Data Management and Statistics services; Protocol and Report writing expertise